Mestastop Solutions, an India-based Biotechnology startup, raised Rs 1.3 crore in a seed funding round led by CIIE.CO, with participation from IKP Knowledge Park and Angels.

Mestastop will use the funding to scale its AI-based platform METSCAN, which characterizes cancer cells using patient data samples and assay panels to understand the cell behavior. It will be further utilized for running PoC animal model studies to validate proof of concept for cancer drug discovery and repurposing.

Company: Mestastop Solutions Pvt. Ltd.

Raised: Rs 1.3 crore

Round: Seed Round

Funding Month: October 2021

Lead Investors: CIIE.CO

Additional Investors: IKP Knowledge Park and Angels

Company Website: https://mestastop.com/

Software Category: Cancer metastasis-focused platform

About the Company: Founded in 2018, the Bengaluru-based company has a cross-functional team, trained in discovery, diagnostics, and AI, supported by state-of-the-art infrastructure. Dr. Arnab Roy Chowdhury and his wife Dr. Debabani Roy Chowdhury are the brains behind Mestastop, which looks at revolutionizing cancer treatment. Mestastop is creating a cancer metastasis-focused platform that uses wet-lab biology and predictive analytics to identify and distinguish unique properties of metastasis and leverage them for drug discovery and patient treatment. Mestastop has developed three proprietary platforms - METAssay, METSCAN, and METVivo to unravel metastasis drug discovery and predictive diagnostics. 

Source: https://www.business-standard.com/article/companies/mestastop-solutions-raises-rs-1-3-cr-in-seed-round-led-by-ciie-co-121101900518_1.html